Standout Papers
Citation Impact
Citing Papers
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults
2007
Primary thromboprophylaxis for cancer patients with central venous catheters – a reappraisal of the evidence
2006
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery
2006
A Population-Based Study of the Effectiveness of Inferior Vena Cava Filter Use Among Patients With Venous Thromboembolism
2000
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Pulmonary Embolism
1998
Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis
2013
Pancreatic cancer
2004 Standout
Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study
2012
Günther Tulip Retrievable Vena Cava Filter: Results from the Registry of the Canadian Interventional Radiology Association
2001
A view on drug resistance in cancer
2019 StandoutNature
Breast cancer
2016 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Silent Pulmonary Embolism in Patients with Deep Venous Thrombosis: A Systematic Review
2010
Intracerebral haemorrhage
2009 Standout
Deep venous thrombosis after percutaneous insertion of vena caval filters
1999
Venous thromboembolism in laparoscopic surgery
2003
Evidence-Based Management of Anticoagulant Therapy
2012
Long-Term Follow-Up of Trauma Patients with a Vena Caval Filter
2000
Postthrombotic Syndrome in Relation to Vena Cava Filter Placement: A Systematic Review
2008
In Vitro Metabolism of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Liver Microsomes and Hepatocytes of Rats, Dogs, and Humans
2009
Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta‐analysis
2014
Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism
1999
Prevention of venous thromboembolism
2001
Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis
2014
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients
2004
Evaluating Meta-analyses in the General Surgical Literature
2005
Prophylactic and Therapeutic Inferior Vena Cava Filters to Prevent Pulmonary Emboli in Trauma Patients
2002
Antithrombotic Therapy in Patients with Any Form of Intracranial Haemorrhage: A Systematic Review of the Available Controlled Studies
2002
Oral Anticoagulant Therapy
2012 Standout
Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy
2001
Reporting Standards for Endovascular Treatment of Lower Extremity Deep Vein Thrombosis
2006
Antithrombotic Therapy for VTE Disease
2016 Standout
The role of vena caval filters in the management of venous thromboembolism
2004
Update on Inferior Vena Cava Filters
2003
Treatment for superficial thrombophlebitis of the leg
2007
Prognostic Value of ECG Among Patients with Acute Pulmonary Embolism and Normal Blood Pressure
2009
Clinical Recognition of Pulmonary Embolism: Problem of Unrecognized and Asymptomatic Cases
1998
The 6-F Nitinol TrapEase Inferior Vena Cava Filter: Results of a Prospective Multicenter Trial
2001
Antiplatelet therapy: Controversial aspects
2011
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects
2016
The Influence of Patient Adherence on Anticoagulation Control With Warfarin
2007
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double‐blind comparison
2007
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis
2010
Deep-vein thrombosis
1999
Are temporary inferior vena cava filters really temporary?
2005
The percutaneous Greenfield filter: Outcomes and practice patterns
2000
Treatment of Deep-Vein Thrombosis
2004
Duplex scan–directed placement of inferior vena cava filters: A five-year institutional experience
2002
The Effect of Low Molecular Weight Heparin Thromboprophylaxis on Bleeding Complications After Gastric Cancer Surgery
2010
Prevention of fatal pulmonary embolism and mortality in surgical patients
2005
Enoxaparin for thromboprophylaxis after major trauma: Potential cost implications
2001
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays
2014 StandoutNobel
Twenty-one-Year Trends in the Use of Inferior Vena Cava Filters
2004
Pulmonary embolism and deep vein thrombosis
2012
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial
2012
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Antithrombotic Therapy for VTE Disease
2012 Standout
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
Deep Venous Thrombosis
2004
Platelet Activation and Atherothrombosis
2007 Standout
Simplification of the Pulmonary Embolism Severity Index for Prognostication in Patients With Acute Symptomatic Pulmonary Embolism
2010
The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism
2010
Fondaparinux for Isolated Superficial Vein Thrombosis of the Legs
2011
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
The Role of Temporary Inferior Vena Cava Filters in Critically Ill Surgical Patients
2003
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Impact of Vena Cava Filters on In-hospital Case Fatality Rate from Pulmonary Embolism
2012
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Venous thromboembolism (VTE) in Europe
2007 Standout
Medical management of patients with brain tumors
2006
Prophylactic vena cava filters for trauma patients: a systematic review of the literature
2003
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Malignant Gliomas in Adults
2008 Standout
Medical literature, vena cava filters and evidence of efficacy
2013
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2008 Standout
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
A prospective observational study of IVC filters in pediatric patients
2008
Medical Literature and Vena Cava Filters
2002
Major Pulmonary Embolism
2002
Clinical Characteristics, Management, and Outcomes of Patients Diagnosed With Acute Pulmonary Embolism in the Emergency Department
2011
The Inferior Vena Cava Filter
2013
Guidelines for the Use of Retrievable and Convertible Vena Cava Filters: Report from the Society of Interventional Radiology Multidisciplinary Consensus Conference
2006
Pulmonary thromboembolic disease spectrum: diagnostic and therapeutic strategies
2009
Effect of Study Setting on Anticoagulation Control
2006
Retrievable Vena Cava Filters for Preventing Pulmonary Embolism in Trauma Patients: A Cautionary Tale
2006
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points
2004
Vena Cava Filter Occlusion and Venous Thromboembolism Risk in Persistently Anticoagulated Patients
2009
Prevention of Venous Thromboembolism
2008 Standout
Development of a Research Agenda for Inferior Vena Cava Filters: Proceedings from a Multidisciplinary Research Consensus Panel
2009
Cost Effectiveness of Dalteparin for Preventing Venous Thromboembolism in Abdominal Surgery
2005
Outcomes and Cost of Deep Venous Thrombosis Among Patients With Cancer
2004
Mechanical thrombectomy in patients with deep venous thrombosis
2001
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
2012
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Risk factors for catheter‐related thrombosis (CRT) in cancer patients: a patient‐level data (IPD) meta‐analysis of clinical trials and prospective studies
2010
Modern surgical treatment of massive pulmonary embolism: Results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach
2005
Use of Retrievable Compared to Permanent Inferior Vena Cava Filters: A Single-Institution Experience
2007
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Deep vein thrombosis
2005
Retrievable Inferior Vena Cava filters are not getting retrieved
2010
Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up
2009
Recommended Reporting Standards for Vena Caval Filter Placement and Patient Follow-Up
1999
Prospective validation of the Pulmonary Embolism Severity Index
2008
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Catheter-directed interventions for acute pulmonary embolism
2014
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Pancreatic cancer and thromboembolic disease
2004
The Rate of Bleeding Complications After Pharmacologic Deep Venous Thrombosis Prophylaxis
2006
Low-Molecular-Weight Heparin vs Unfractionated Heparin for Perioperative Thromboprophylaxis in Patients With Cancer<subtitle>A Systematic Review and Meta-analysis</subtitle>
2008
Prevention of Venous Thromboembolism
1998
Hemorrhagic Complications of Anticoagulant Treatment
2004
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
A Systematic Review of Deep Venous Thrombosis Prophylaxis in Cancer Patients: Implications for Improving Quality
2006
Prospective randomized study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters
2010
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines
2012
In-Vivo Quantitative Proteomics Reveals a Key Contribution of Post-Transcriptional Mechanisms to the Circadian Regulation of Liver Metabolism
2014
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Pancreatic cancer
2011 Standout
Cancer-associated thrombosis: investigating the role of new oral anticoagulants
2015
Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy
2000
Venous Thromboembolism
1999
Deep-vein thrombosis in high-energy skeletal trauma despite thromboprophylaxis
2005
Treatment for superficial thrombophlebitis of the leg
2013
Fibrinolysis for acute pulmonary embolism
2010
Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread
1999
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
Vena caval filters: a comprehensive review
2000
Endovascular Treatment for Iliac Vein Compression Syndrome: a Comparison between the Presence and Absence of Secondary Thrombosis
2009
Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients
2003
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
2014
Interventions for enhancing medication adherence
2008 Standout
Anticoagulation or Inferior Vena Cava Filter Placement for Patients With Primary Intracerebral Hemorrhage Developing Venous Thromboembolism?
2003
Natural History of Venous Thromboembolism
2003
A circadian gene expression atlas in mammals: Implications for biology and medicine
2014 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery
2009
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
2007
The Role of Surveillance Duplex Scanning in Preventing Venous Thromboembolism in Trauma Patients
2002
The management of venous thromboembolism in cancer patients
2007
Prolonged thromboprophylaxis with Low Molecular Weight heparin for abdominal or pelvic surgery
2009
Interventions for enhancing medication adherence
2014 Standout
Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism
2004
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
2003
Superficial Venous Thrombosis and Venous Thromboembolism
2010
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer
2014
Massive Pulmonary Embolism
2006
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939)
2007
Axial and Reformatted Four-Chamber Right Ventricle–to–Left Ventricle Diameter Ratios on Pulmonary CT Angiography as Predictors of Death After Acute Pulmonary Embolism
2012
Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)
2004
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2013
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
2004
Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review.
2005
Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial
2013
Rivaroxaban: A New Oral Factor Xa Inhibitor
2010
Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery
2005
Works of Silvy Laporte being referenced
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Individual patient data meta‐analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patients
2011
New oral antithrombotics: a need for laboratory monitoring. For
2010
Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays
2013
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer
2006
Circadian Dynamics of Coagulation and Chronopathology of Cardiovascular and Cerebrovascular Events
1991
Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs
2010
Pharmacology of cytotoxic agents: a helpful tool for building dose adjustment guidelines in the elderly
2003
Impact of double‐blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta‐analysis
2013
Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis
2010
Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis
2003
A Prospective Long-term Study of 220 Patients With a Retrievable Vena Cava Filter for Secondary Prevention of Venous Thromboembolism
2007
Survival Effects of Inferior Vena Cava Filter in Patients With Acute Symptomatic Venous Thromboembolism and a Significant Bleeding Risk
2014
Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta‐analysis
2004
Diagnosis of Pulmonary Embolism in Patients with Proximal Deep Vein Thrombosis
2001
Ximelagatran and melagatran vs. low‐molecular‐weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration
2005
Prediction of survival benefits from progression-free survival in patients with advanced non small cell lung cancer: Evidence from a pooled analysis of 2,838 patients randomized in 7 trials
2008
Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
2003
Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism
2008
Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial
2003
Consistency of Effect of Docetaxel-Containing Adjuvant Chemotherapy in Patients with Early Stage Breast Cancer Independent of Nodal Status: Meta-Analysis of 12 Randomized Clinical Trials.
2009
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
2001